The granulocyte macrophage colony-stimulating factor (GM-CSF) fusion proteins are potent B-cell lymphoma immunotherapeutic vaccines (Yang et al., 2005). The gene discussed is CSF2; the disease is B-cell non-Hodgkin lymphoma.